KALEIDO BIOSCIENCES, INC. Operating Expenses
KALEIDO BIOSCIENCES, INC. reported Operating Expenses of $88.77 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2022-04-01
- KALEIDO BIOSCIENCES, INC. operating expenses for the quarter ending 2021-12-31 was $20.19M, a 3.32% increase year-over-year.
- KALEIDO BIOSCIENCES, INC. operating expenses for the quarter ending 2021-09-30 was $22.52M, a 1.50% decline year-over-year.
- KALEIDO BIOSCIENCES, INC. operating expenses for the quarter ending 2021-06-30 was $23.42M, a 27.33% increase year-over-year.
- KALEIDO BIOSCIENCES, INC. operating expenses for the quarter ending 2021-03-31 was $22.64M, a 18.85% increase year-over-year.
- KALEIDO BIOSCIENCES, INC. operating expenses for fiscal 2021 was $88.77M, a 11.17% increase from fiscal 2020.
- KALEIDO BIOSCIENCES, INC. operating expenses for fiscal 2020 was $79.85M, a 7.86% decline from fiscal 2019.
- KALEIDO BIOSCIENCES, INC. operating expenses for fiscal 2019 was $86.66M, a 42.81% increase from fiscal 2018.
- KALEIDO BIOSCIENCES, INC. operating expenses for fiscal 2018 was $60.68M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2021-12-31 | $20.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01 | $42.71M derived: sum of 2 quarters · filed 2022-04-01 | $66.13M derived: sum of 3 quarters · filed 2022-04-01 | $88.77M 10-K · filed 2022-04-01 |
| 2021-09-30 | $22.52M 10-Q · filed 2021-11-01 | $45.94M derived: sum of 2 quarters · filed 2021-11-01 | $68.58M 10-Q · filed 2021-11-01 | $88.12M derived: sum of 4 quarters · filed 2022-04-01 |
| 2021-06-30 | $23.42M 10-Q · filed 2021-08-11 | $46.06M 10-Q · filed 2021-08-11 | $65.61M derived: sum of 3 quarters · filed 2022-04-01 | $88.47M derived: sum of 4 quarters · filed 2022-04-01 |
| 2021-03-31 | $22.64M 10-Q · filed 2021-05-04 | $42.19M derived: sum of 2 quarters · filed 2022-04-01 | $65.05M derived: sum of 3 quarters · filed 2022-04-01 | $83.44M derived: sum of 4 quarters · filed 2022-04-01 |
| 2020-12-31 | $19.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01 | $42.40M derived: sum of 2 quarters · filed 2022-04-01 | $60.80M derived: sum of 3 quarters · filed 2022-04-01 | $79.85M 10-K · filed 2022-04-01 |
| 2020-09-30 | $22.86M 10-Q · filed 2021-11-01 | $41.25M derived: sum of 2 quarters · filed 2021-11-01 | $60.31M 10-Q · filed 2021-11-01 | $79.28M derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | $18.39M 10-Q · filed 2021-08-11 | $37.45M 10-Q · filed 2021-08-11 | $56.42M derived: sum of 3 quarters · filed 2021-08-11 | $78.53M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $19.05M 10-Q · filed 2021-05-04 | $38.02M derived: sum of 2 quarters · filed 2021-05-04 | $60.14M derived: sum of 3 quarters · filed 2021-05-04 | $85.10M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $18.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $41.09M derived: sum of 2 quarters · filed 2021-03-03 | $66.05M derived: sum of 3 quarters · filed 2021-03-03 | $86.66M 10-K · filed 2021-03-03 |
| 2019-09-30 | $22.12M 10-Q · filed 2020-11-02 | $47.07M derived: sum of 2 quarters · filed 2020-11-02 | $67.69M 10-Q · filed 2020-11-02 | $88.49M derived: sum of 4 quarters · filed 2020-11-02 |
| 2019-06-30 | $24.96M 10-Q · filed 2020-08-04 | $45.57M 10-Q · filed 2020-08-04 | $66.38M derived: sum of 3 quarters · filed 2020-08-04 | $83.69M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $20.61M 10-Q · filed 2020-05-14 | $41.42M derived: sum of 2 quarters · filed 2020-05-14 | $58.73M derived: sum of 3 quarters · filed 2020-05-14 | $71.08M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $20.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $38.12M derived: sum of 2 quarters · filed 2020-03-02 | $50.47M derived: sum of 3 quarters · filed 2020-03-02 | $60.68M 10-K · filed 2020-03-02 |
| 2018-09-30 | $17.31M 10-Q · filed 2019-10-30 | $29.66M derived: sum of 2 quarters · filed 2019-10-30 | $39.88M 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $12.35M 10-Q · filed 2019-08-01 | $22.57M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $10.22M 10-Q · filed 2019-05-02 |